Literature DB >> 24515941

Encephalitis-associated hospitalizations among American Indians and Alaska Natives.

Jason M Mehal1, Robert C Holman, Neil M Vora, Jesse Blanton, Paul H Gordon, James E Cheek.   

Abstract

Encephalitis produces considerable morbidity in the United States, but morbidity rates among American Indian/Alaska Native (AI/AN) people have not been described. Hospitalization records listing an encephalitis diagnosis were analyzed by using Indian Health Service direct/contract inpatient data. For 1998-2010, there were 436 encephalitis-associated hospitalizations among AI/AN people, an average annual age-adjusted hospitalization rate of 3.1/100,000 population. The rate for infants (11.9) was more than double that for any other age group. Death occurred for 4.1% of hospitalizations. Consistent with reports for the general U.S. population, the rate was high among infants and most (53.9%) hospitalizations were of unexplained etiology. The average annual rate during the study period appeared lower than for the general U.S. population, due particularly to lower rates in the elderly. Future community-based surveillance and mortality studies are needed to confirm these findings and examine reasons underlying the low rates of encephalitis in AI/AN people.

Entities:  

Mesh:

Year:  2014        PMID: 24515941      PMCID: PMC3973525          DOI: 10.4269/ajtmh.13-0420

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  28 in total

1.  Age adjustment using the 2000 projected U.S. population.

Authors:  R J Klein; C A Schoenborn
Journal:  Healthy People 2010 Stat Notes       Date:  2001-01

2.  Longitudinal Gompertzian analysis of amyotrophic lateral sclerosis mortality in the U.S., 1977-1986: evidence for an inherently susceptible population subset.

Authors:  J E Riggs
Journal:  Mech Ageing Dev       Date:  1990-09       Impact factor: 5.432

Review 3.  Issues and updates in emerging neurologic viral infections.

Authors:  Michael R Wilson; Kenneth L Tyler
Journal:  Semin Neurol       Date:  2011-09-30       Impact factor: 3.420

Review 4.  Challenge of the unknown. A systematic review of acute encephalitis in non-outbreak situations.

Authors:  J Granerod; C C Tam; N S Crowcroft; N W S Davies; M Borchert; S L Thomas
Journal:  Neurology       Date:  2010-09-07       Impact factor: 9.910

Review 5.  Acute encephalitis.

Authors:  R T Johnson
Journal:  Clin Infect Dis       Date:  1996-08       Impact factor: 9.079

6.  Trend of hospital utilization for encephalitis.

Authors:  P Barbadoro; A Marigliano; A Ricciardi; M M D'Errico; E Prospero
Journal:  Epidemiol Infect       Date:  2011-06-21       Impact factor: 2.451

7.  Changing mortality for motor neuron disease in France (1968-2007): an age-period-cohort analysis.

Authors:  Paul H Gordon; Fanny Artaud; Albertine Aouba; Françoise Laurent; Vincent Meininger; Alexis Elbaz
Journal:  Eur J Epidemiol       Date:  2011-06-15       Impact factor: 8.082

8.  Burden of encephalitis-associated hospitalizations in the United States, 1998-2010.

Authors:  Neil M Vora; Robert C Holman; Jason M Mehal; Claudia A Steiner; Jesse Blanton; James Sejvar
Journal:  Neurology       Date:  2014-01-02       Impact factor: 9.910

9.  Epidemiology of infectious encephalitis, differences between a prospective study and hospital discharge data.

Authors:  S Bernard; A Mailles; J P Stahl
Journal:  Epidemiol Infect       Date:  2012-11-21       Impact factor: 4.434

10.  Etiology of encephalitis in Australia, 1990-2007.

Authors:  Clare Huppatz; David N Durrheim; Christopher Levi; Craig Dalton; David Williams; Mark S Clements; Paul M Kelly
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more
  1 in total

1.  Trends in Pelvic Inflammatory Disease Among American Indian and Alaska Native Women, Indian Health Service, 2001-2015.

Authors:  Andria Apostolou; Christina Chapman; Marissa Person; Kristen Kreisel; Jeffrey McCollum
Journal:  Am J Public Health       Date:  2018-09-25       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.